Market Exclusive

Analyst Activity – William Blair Reiterates Outperform on Atara Biotherapeutics (NASDAQ:ATRA)

Analyst Ratings For Atara Biotherapeutics (NASDAQ:ATRA)

Today, William Blair reiterated its Outperform rating on Atara Biotherapeutics (NASDAQ:ATRA).

Some recent analyst ratings include

Recent Insider Trading Activity For Atara Biotherapeutics (NASDAQ:ATRA)
Atara Biotherapeutics (NASDAQ:ATRA) has insider ownership of 16.20% and institutional ownership of 76.88%.

Recent Trading Activity for Atara Biotherapeutics (NASDAQ:ATRA)
Shares of Atara Biotherapeutics closed the previous trading session at 39.00 up +0.33 0.84% with shares trading hands.

Exit mobile version